Dimensional Fund Advisors LP Buys 30,464 Shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR)

Dimensional Fund Advisors LP raised its stake in Nature’s Sunshine Products, Inc. (NASDAQ:NATR) by 3.7% in the 4th quarter, HoldingsChannel.com reports. The firm owned 856,701 shares of the company’s stock after acquiring an additional 30,464 shares during the period. Dimensional Fund Advisors LP’s holdings in Nature’s Sunshine Products were worth $12,560,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the stock. Russell Investments Group Ltd. purchased a new position in shares of Nature’s Sunshine Products in the fourth quarter worth $41,000. Amundi purchased a new position in shares of Nature’s Sunshine Products in the fourth quarter valued at about $63,000. Wells Fargo & Company MN raised its stake in shares of Nature’s Sunshine Products by 28.8% during the fourth quarter. Wells Fargo & Company MN now owns 7,209 shares of the company’s stock valued at $106,000 after acquiring an additional 1,611 shares during the last quarter. Proficio Capital Partners LLC bought a new position in shares of Nature’s Sunshine Products during the fourth quarter valued at about $200,000. Finally, Bailard Inc. purchased a new stake in shares of Nature’s Sunshine Products during the fourth quarter worth about $302,000. Hedge funds and other institutional investors own 79.40% of the company’s stock.

Nature’s Sunshine Products Trading Down 3.6 %

Shares of NATR stock opened at $13.80 on Friday. Nature’s Sunshine Products, Inc. has a 12-month low of $10.81 and a 12-month high of $18.06. The stock has a market capitalization of $255.08 million, a P/E ratio of 15.68 and a beta of 1.10. The firm’s 50 day moving average is $12.57 and its 200 day moving average is $14.04.

Nature’s Sunshine Products (NASDAQ:NATR) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.16 by $0.09. Nature’s Sunshine Products had a return on equity of 11.08% and a net margin of 3.81%. The company had revenue of $113.25 million during the quarter, compared to analyst estimates of $109.39 million.

Analyst Upgrades and Downgrades

Separately, DA Davidson started coverage on Nature’s Sunshine Products in a report on Wednesday. They issued a “buy” rating and a $19.00 price objective for the company.

About Nature’s Sunshine Products

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.